.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Citi
Johnson and Johnson
Queensland Health
Fuji
Accenture
Harvard Business School
US Army
Novartis
QuintilesIMS

Generated: June 25, 2017

DrugPatentWatch Database Preview

PRED-G Drug Profile

« Back to Dashboard

Which patents cover Pred-g, and what generic Pred-g alternatives are available?

Pred-g is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in PRED-G is gentamicin sulfate; prednisolone acetate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gentamicin sulfate; prednisolone acetate profile page.

Summary for Tradename: PRED-G

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list51
Clinical Trials: see list38
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRED-G at DailyMed

Pharmacology for Tradename: PRED-G

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
PRED-G
gentamicin sulfate; prednisolone acetate
OINTMENT;OPHTHALMIC050612-001Dec 1, 1989RXYesYes► Subscribe► Subscribe
Allergan
PRED-G
gentamicin sulfate; prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC050586-001Jun 10, 1988RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Moodys
US Army
McKinsey
Queensland Health
Dow
Fish and Richardson
Healthtrust
QuintilesIMS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot